Deep, focused subsequent-era sequencing has discovered that subclonal mutations (i.e., All those current in only a fraction of tumor cells) might be detected for all driver genes and so are affiliated with immediate disease development and very poor outcome.11–thirteen This is especially suitable for TP53 mutations given The point that, as spelle